Vaccinia virus biochemical genetics
痘苗病毒生化遗传学
基本信息
- 批准号:8053536
- 负责人:
- 金额:$ 10.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-12 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBiochemicalBiochemical GeneticsCellsCodeComplexCoupledDNADNA Replication FactorDNA biosynthesisDNA replication forkDNA-Directed RNA PolymeraseDNA-dependent ATPaseDiseaseElongation FactorEndoribonucleasesEnzymesEssential GenesEukaryotaEventGene ExpressionGene Expression RegulationGenesGenetic RecombinationGenetic TranscriptionGoalsIn VitroIntegration Host FactorsMediatingMessenger RNAModelingMolecularNucleic Acid BindingPhosphoproteinsPhosphorylationPlayPoxviridaeProcessProkaryotic CellsPropertyProteinsPublic HealthRNAReactionRecombinant ProteinsRegulationResearchRoleSmall Interfering RNASourceStudy modelsSystemTestingTranscription ElongationTranscriptional RegulationVacciniaVaccinia virusViralViral ProteinsVirusVirus DiseasesVirus ReplicationVirus-Cell Membrane InteractionWorkdesignendoribonucleasehelicasein vivoinsightinterestmutantoncolytic vectorpublic health relevancereconstitutionrelease factorresearch studytermination factortherapeutic proteintooltranscription terminationviral DNAviral RNAweapons
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to understand the molecular mechanisms governing post-initiation events in postreplicative gene transcription during vaccinia virus infection. In recent years it has become increasingly clear that post-initiation events in transcription, including transcription elongation, termination and RNA cleavage, comprise important control points for regulation of gene expression in both prokaryotes and eukaryotes. Our recent work suggests that postreplicative mRNA 3' end formation during vaccinia virus infection is a concerted process that involves both transcription termination and RNA cleavage, that it is coupled to viral DNA replication, and that it is mediated by both viral and host factors in a dynamic complex. The factors include a viral RNA release factor (A18), a viral RNA cleavage/transcription/DNA replication factor (H5), two viral positive transcription elongation factors (G2 and J3), and at least two host factors required for A18 RNA release activity and for RNA cleavage. This project comprises two aims, focusing on understanding the mechanism of transcription termination and endoribonucleolytic RNA cleavage. Studies of termination (Aim 1) involve mechanistic studies on A18 and its required host factor, and studies of mRNA cleavage (Aim 2) involve mechanistic studies of an endoribonuclease comprised of the viral H5 protein and host proteins. The viral gene products under study are highly conserved among vertebrate poxviruses, they are essential for virus replication, they all unquestionably collaborate in mediating postreplicative gene transcription elongation and termination, and yet their precise roles in these processes are only partially understood. The research proposed here will significantly refine our understanding of the roles of these essential genes in poxvirus replication, and it will also impact on our understanding of the interaction between the virus and the host cell. The results will provide critical insight into fundamental mechanisms of vaccinia virus gene expression in particular, and the system may prove to be an important model for study of regulation of transcription elongation in eukaryotes in general. PUBLIC HEALTH RELEVANCE: This project is relevant to public health on three levels. First, it advances our understanding of the basic mechanisms of eukaryotic transcriptional regulation of gene expression, which in turn is a central part of the normal framework on which our understanding of disease is built. Second, it advances our understanding of the molecular mechanisms of virus replication and virus cell interactions, which has implications in general for treatment of virus induced disease. Third, the project provides insight specifically into the replication of poxviruses, which are of particular interest to public health as research tools, as a source of therapeutic proteins, as oncolytic vectors, and as potential bioterrorist weapons.
描述(由申请人提供):本项目的目标是了解牛痘病毒感染过程中复制后基因转录起始后事件的分子机制。近年来,人们越来越清楚,转录起始后事件,包括转录延伸、终止和RNA切割,是原核生物和真核生物基因表达调控的重要控制点。我们最近的研究表明,在牛痘病毒感染过程中,复制后mRNA 3'端形成是一个包括转录终止和RNA切割的协同过程,它与病毒DNA复制相耦合,并且在一个动态复合体中由病毒和宿主因子共同介导。这些因子包括一个病毒RNA释放因子(A18),一个病毒RNA切割/转录/DNA复制因子(H5),两个病毒阳性转录延伸因子(G2和J3),以及至少两个A18 RNA释放活性和RNA切割所需的宿主因子。本项目包括两个目标,重点是了解转录终止机制和核糖核酸内溶RNA切割。终止研究(Aim 1)涉及对A18及其所需宿主因子的机制研究,mRNA切割研究(Aim 2)涉及由病毒H5蛋白和宿主蛋白组成的核糖核酸内切酶的机制研究。所研究的病毒基因产物在脊椎动物痘病毒中是高度保守的,它们是病毒复制所必需的,它们毫无疑问都在介导复制后基因转录的延伸和终止中协同作用,但它们在这些过程中的确切作用仅被部分了解。这里提出的研究将大大完善我们对这些必要基因在痘病毒复制中的作用的理解,它也将影响我们对病毒与宿主细胞之间相互作用的理解。该研究结果将对牛痘病毒基因表达的基本机制提供重要的见解,并且该系统可能被证明是研究真核生物转录延伸调控的重要模型。公共卫生相关性:本项目在三个层面上与公共卫生相关。首先,它促进了我们对真核生物转录调控基因表达的基本机制的理解,这反过来又是我们对疾病的理解所建立的正常框架的核心部分。其次,它促进了我们对病毒复制和病毒细胞相互作用的分子机制的理解,这对病毒诱导疾病的治疗具有普遍意义。第三,该项目提供了对痘病毒复制的具体见解,作为研究工具,作为治疗性蛋白质的来源,作为溶瘤载体,以及作为潜在的生物恐怖主义武器,痘病毒对公共卫生特别感兴趣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard C Condit其他文献
Richard C Condit的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard C Condit', 18)}}的其他基金
相似海外基金
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
- 批准号:
39579-2007 - 财政年份:2011
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
- 批准号:
39579-2007 - 财政年份:2010
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Lipolysis: Biochemical Genetics, Physiology and Molecular Circuitry
脂肪分解:生化遗传学、生理学和分子回路
- 批准号:
201793 - 财政年份:2010
- 资助金额:
$ 10.14万 - 项目类别:
Operating Grants
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
- 批准号:
39579-2007 - 财政年份:2009
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
- 批准号:
39579-2007 - 财政年份:2008
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
- 批准号:
39579-2007 - 财政年份:2007
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
- 批准号:
39579-2002 - 财政年份:2006
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
- 批准号:
39579-2002 - 财政年份:2005
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
- 批准号:
39579-2002 - 财政年份:2004
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
- 批准号:
39579-2002 - 财政年份:2003
- 资助金额:
$ 10.14万 - 项目类别:
Discovery Grants Program - Individual